Charles River Laboratories International, Inc. (CRL)
NYSE·Healthcare·Medical - Diagnostics & Research
$278.04
-1.25%
Mkt Cap $13.40B
Analyst Ratings
Buy
12
Hold
3
Sell
0
Price Target (43 analysts)
$222.11
Range $192.00 – $250.00
Implied Upside
-20.1%
Consensus $222.11 vs current $278.04